Fourth dose of the SARS-CoV-2 vaccine in kidney transplant recipients with previously impaired humoral antibody response.

Midtvedt, Karsten; Vaage, John Torgils; Heldal, Kristian; Munthe, Ludvig A; Lund-Johansen, Fridtjof; Åsberg, Anders

Midtvedt, Karsten; Vaage, John Torgils; Heldal, Kristian; Munthe, Ludvig A; Lund-Johansen, Fridtjof; Åsberg, Anders.

Midtvedt K; Department of Transplantation Medicine, Oslo University Hospital-Rikshospitalet, Oslo, Norway.
Vaage JT; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Heldal K; Department of Immunology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Munthe LA; Department of Transplantation Medicine, Oslo University Hospital-Rikshospitalet, Oslo, Norway.
Lund-Johansen F; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Åsberg A; Department of Immunology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Am J Transplant ; 22(11): 2704-2706, 2022 Nov.

Article in English | MEDLINE | ID: covidwho-1831930

Subject(s)

COVID-19; Kidney Transplantation; Humans; Antibody Formation; COVID-19 Vaccines; COVID-19/prevention & control; SARS-CoV-2; Antibodies, Viral; Transplant Recipients

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Kidney Transplantation / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Am J Transplant Journal subject: Transplantation Year: 2022 Document Type: Article Affiliation country: Ajt.17091

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google